Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
A genetic model for colorectal tumorigenesis
1990 • 11,800 citations
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
1987 • 11,429 citations
Mutations in the p53 gene occur in diverse human tumour types
1989 • 2,765 citations
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
1986 • 1,226 citations
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
1990 • 1,080 citations
Neu-Protein Overexpression in Breast Cancer
1988 • 860 citations
P53 expression in breast cancer
1988 • 612 citations
Intraductal carcinoma of the breast: Follow-up after biopsy only
1982 • 604 citations
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
1989 • 592 citations
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
1988 • 570 citations
Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
1989 • 563 citations
Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
1990 • 511 citations
Reduction to Homozygosity of Genes on Chromosome 11 in Human Breast Neoplasia
1987 • 329 citations
Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
1989 • 321 citations
Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone
1978 • 308 citations
Heterogeneity of intraductai carcinoma of the breast
1989 • 250 citations
Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.
1987 • 247 citations
Maintenance of p53 alterations throughout breast cancer progression.
1991 • 244 citations
p53 mutations in breast cancer.
1992 • 243 citations
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.
1992 • 196 citations
Intracystic papillary carcinoma of the breast after mastectomy, radiotherapy or excisional biopsy alone
2006 • 179 citations
Characterization and Chromosome Assignment of the Human Homolog of int-2, a Potential Proto-Oncogene
1986 • 178 citations
Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions
1994 • 178 citations
Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
1991 • 174 citations
Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.
1992 • 162 citations
correlation between histologic grade of malignancy and copy number of c-erbb-2 gene in breast carcinoma. A retrospective analysis of 176 cases
1990 • 152 citations
The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
1989 • 114 citations
Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
1994 • 110 citations
p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade
1993 • 86 citations
Breast conservation therapy for intraductal carcinoma of the breast
1993 • 80 citations
Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
1993 • 73 citations
Different Incidence of Loss of Heterozygosity on Chromosome 16q between Intraductal Papilloma and Intracystic Papillary Carcinoma of the Breast
1994 • 33 citations
Cited By (0)
No citing papers found in database